Advertisement

Transient Deficiencies of T-Cell-Mediated Immunity in the Neonate

  • David A. Randolph
  • David B. Lewis
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 582)

5. Conclusion

In summary, neonates demonstrate striking deficiencies in cell-mediated immunity to a number of pathogens. A number of carefully orchestrated cellular and molecular events must occur before a strong cell-mediated immune response can be mounted, and newborns are transiently deficient at a number of points along the way. Neonatal antigen presenting function is less efficient than that of adults, and, in particular neonatal dendritic cells secrete less IL-12. Neonatal CD4 cells are prevented from differentiating into Th1 cells due to decreased levels of STAT4 and epigenetic regulation of the IFN-γ promoter. They also express less CD154. Consequently, the normal positive feedback loops for driving cell-mediated immunity, in which IFN-γ and CD154 from T cells induce dendritic cells to produce more IL-12, are interrupted. A better understanding of these mechanisms will be important in the care of newborns as well as in vaccine development.

Keywords

Dendritic Cell Herpes Simplex Virus Infection Congenital Infection Myeloid Dendritic Cell Adult Peripheral Blood 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adkins, B. (1999). T-cell function in newborn mice and humans. Immunol. Today 20, 330–335.PubMedCrossRefGoogle Scholar
  2. Adkins, B., Leclerc, C., and Marshall-Clarke, S. (2004). Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4, 553–564.PubMedCrossRefGoogle Scholar
  3. Ameratunga, R., Lederman, H.M., Sullivan, K.E., Ochs, H.D., Seyama, K., French, J.K. et al. (1997). Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J. Pediatr. 131, 147–150.PubMedCrossRefGoogle Scholar
  4. Bevan, M. (2004). Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 4, 595–602.PubMedCrossRefGoogle Scholar
  5. Brown, H.L., and Abernathy, M.P. (1998). Cytomegalovirus infection. Semin. Perinatol. 22, 260–266.PubMedCrossRefGoogle Scholar
  6. Burchett, S.K., Corey, L., Mohan, K.M., Westall, J., Ashley, R., and Wilson, C.B. (1992). Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J. Infect. Dis. 165, 813–818.PubMedGoogle Scholar
  7. Chaplin, D.D. (2003). 1. Overview of the immune response. J. Allergy Clin. Immunol. 111, S442–459.PubMedCrossRefGoogle Scholar
  8. Chen, L., Cohen, A.C., and Lewis, D.B. (2006). Impaired allogeneic activation and T helper 1 differentiation of human cord blood naive CD4 T cells. Biol. Blood Marrow Transplant. 12: 160–171.PubMedCrossRefGoogle Scholar
  9. Chen, S.F., Tu, W.W., Sharp, M.A., Tongson, E.C., He, X.S., and Greenberg, H.B., et al. (2004). Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. J. Infect. Dis. 189, 1619–1627.PubMedCrossRefGoogle Scholar
  10. Clerici, M., DePalma, L., Roilides, E., Baker, R., and Shearer, G.M. (1993). Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J. Clin. Invest. 91, 2829–2836.PubMedGoogle Scholar
  11. Cresswell, P., Ackerman, A.L., Giodini, A., Peaper, D.R., and Wearsch, P.A. (2005). Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207, 145–157.PubMedCrossRefGoogle Scholar
  12. Dabbagh, K., Dahl, M.E., Stepick-Biek, P., and Lewis, D.B. (2002). Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J. Immunol. 168, 4524–4530.PubMedGoogle Scholar
  13. Ehlers, S., and Smith, K.A. (1991). Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med. 173, 25–36.PubMedCrossRefGoogle Scholar
  14. Etzioni, A., and Ochs, H.D. (2004). The hyper IgM syndrome — an evolving story. Pediatr. Res. 56, 519–525.PubMedCrossRefGoogle Scholar
  15. Gandhi, M.K., and Khanna, R. (2004). Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4, 725–738.PubMedCrossRefGoogle Scholar
  16. Gasparoni, A., Ciardelli, L., Avanzini, A., Castellazzi, A.M., Carini, R., Rondini, G., and Chirico, G. (2003). Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol. Neonate 84, 297–303.PubMedCrossRefGoogle Scholar
  17. Goriely, S., Vincart, B., Stordeur, P., Vekemans, J., Willems, F., Goldman, M., and De Wit, D. (2001). Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 166, 2141–2146.PubMedGoogle Scholar
  18. Guerina, N.G., Hsu, H.W., Meissner, H.C., Maguire, J.H., Lynfield, R., Stechenberg, B., Abroms, I., Pasternack, M.S., Hoff, R., and Eaton, R.B., et al. (1994). Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N. Engl. J. Med. 330, 1858–1863.PubMedCrossRefGoogle Scholar
  19. Harari, A., Zimmerli, S.C., and Pantaleo, G. (2004). Cytomegalovirus (CMV)-specific cellular immune responses. Hum. Immunol. 65, 500–506.PubMedCrossRefGoogle Scholar
  20. Herget, G.W., Riede, U.N., Schmitt-Graff, A., Lubbert, M., Neumann-Haefelin, D., and Kohler, G. (2005). Generalized herpes simplex virus infection in an immunocompromised patient-report of a case and review of the literature. Pathol. Res. Pract. 201, 123–129.PubMedCrossRefGoogle Scholar
  21. Hermann, E., Truyens, C., Alonso-Vega, C., Even, J., Rodriguez, P., and Berthe, A., et al. (2002). Human fetuses are able to mount an adult-like CD8 T-cell response. Blood 100, 2153–2158.PubMedGoogle Scholar
  22. Hunter, C.A. (2005). New IL-12 family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521–531.PubMedCrossRefGoogle Scholar
  23. Jain, A., Atkinson, T.P., Lipsky, P.E., Slater, J.E., Nelson, D.L., and Strober, W. (1999). Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J. Clin. Invest. 103, 1151–1158.PubMedGoogle Scholar
  24. Jullien, P., Cron, R.Q., Dabbagh, K., Cleary, A., Chen, L., and Tran, P., et al. (2003). Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation. Int. Immunol. 15, 1461–1472.PubMedCrossRefGoogle Scholar
  25. Kimberlin, D.W. (2004). Neonatal herpes simplex infection. Clin. Microbiol. Rev. 17, 1–13.PubMedCrossRefGoogle Scholar
  26. Langrish, C.L., Buddle, J.C., Thrasher, A.J., and Goldblatt, D. (2002). Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin. Exp. Immunol. 128, 118–123.PubMedCrossRefGoogle Scholar
  27. Liu, Y.J. (2001). Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259–262.PubMedCrossRefGoogle Scholar
  28. Lucin, P., Pavic, I., Polic, S., Jonjic, S., and Kosinowski, U.H. (1992). Gamma-interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66, 1977–1984.PubMedGoogle Scholar
  29. Marchant, A., Appay, V., Van Der Sande, M., Dulphy, N., Liesnard, C., and Kidd, M., et al. (2003). Mature CD8(+) T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 111, 1747–1755.PubMedCrossRefGoogle Scholar
  30. Mellman, I., and Steinman, R.M. (2001). Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255–258.PubMedCrossRefGoogle Scholar
  31. Melvin, A.J., McGurn, M.E., Bort, S.J., Gibson, C., and Lewis, D.B. (1995). Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells. Eur. J. Immunol. 25, 426–430.PubMedGoogle Scholar
  32. Montoya, J.G., and Liesenfeld, O. (2004). Toxoplasmosis. Lancet 363, 1965–1976.PubMedCrossRefGoogle Scholar
  33. Nonoyama, S., Penix, L.A., Edwards, C.P., Lewis, D.B., Ito, S., and Aruffo, A., et al. (1995). Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 95, 66–75.PubMedCrossRefGoogle Scholar
  34. O’Sullivan, B., and Thomas, R. (2003). CD40 and dendritic cell function. Crit. Rev. Immunol. 23, 83–107.PubMedCrossRefGoogle Scholar
  35. Peggs, K.S., Verfuerth, S., Pizzey, A., Khan, N., Moss, P., and Goldstone, A.H., et al. (2003). Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection. Biol. Blood Marrow Transplant. 9, 198–205.PubMedCrossRefGoogle Scholar
  36. Picard, C., and Casanova, J.L. (2004) Inherited disorders of cytokines. Curr. Opin. Pediatr. 16, 648–658.PubMedCrossRefGoogle Scholar
  37. Polic, B., Hengel, H., Krmpotic, A., Trgovcich, J., Pavic, P., and Luccaronin, P., et al. (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188, 1047–1054.PubMedCrossRefGoogle Scholar
  38. Pirenne-Ansart, H., Paillard, F., De Groote, D., Eljaafari, A., Le Gac, S., Blot, P., Franchimont, P., Vaquero, C., and Sterkers, G. (1995). Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3-or CD2-activated T cells from neonates. Pediatr. Res. 37, 64–69.PubMedGoogle Scholar
  39. Quezada, S.A., Jarvinen, L.Z., Lind, E.F., and Noelle, R.J. (2004). CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22, 307–328.PubMedCrossRefGoogle Scholar
  40. Schwartz, R.H. (2005). Natural regulatory T cells and self-tolerance. Nat. Immunol. 6, 327–330.PubMedCrossRefGoogle Scholar
  41. Smith, S., Jacobs, R.F., and Wilson, C.B. (1997). Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J. Pediatr. 131, 16–26.PubMedCrossRefGoogle Scholar
  42. Stagno, S., Pass, R.F., Dworsky, M.E., and Alford, C.A. (1983). Congenital and perinatal cytomegalovirus infections. Semin. Perinatol. 7, 31–42.PubMedGoogle Scholar
  43. Subauste, C.S., Wessendarp, M., Sorensen, R.U., and Leiva, L.E. (1999). CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J. Immunol. 162, 6690–6700.PubMedGoogle Scholar
  44. Sullender, W.M., Miller, J.L., Yasukawa, L.L., Bradley, J.S., Black, S.B., Yeager, A.S., and Arvin, A.M. (1987). Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Dis. 155, 28–37.PubMedGoogle Scholar
  45. Takeda, K., and Akira, S. (2005). Toll-like receptors and innate immunity. Int. Immunol. 17, 1–14.PubMedCrossRefGoogle Scholar
  46. Trivedi, H.N., HayGlass, K.T., Gangur, V., Allardice, J.G., Embree, J.E., and Plummer, F.A. (1997). Analysis of neonatal T cell and antigen presenting cell functions. Hum. Immunol. 57, 69–79.PubMedCrossRefGoogle Scholar
  47. Tu, W., Chen, S., Sharp, M., Dekker, C., Manganello, A.M., and Tongson, E.C., et al. (2004). Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J. Immunol. 172, 3260–3267.PubMedGoogle Scholar
  48. Upham, J.W., Lee, P.T., Holt, B.J., Heaton, T., Prescott, S.L., and Sharp, M.J., et al. (2002). Development of interleukin-12-producing capacity throughout childhood. Infect. Immun. 70, 6583–6588.PubMedCrossRefGoogle Scholar
  49. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., and Riddell, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038–1044.PubMedCrossRefGoogle Scholar
  50. Watts, C. (2004). The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5, 685–692.PubMedCrossRefGoogle Scholar
  51. White, G.P., Watt, P.M., Holt, B.J., and Holt, P.G. (2002). Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO-T cells. J. Immunol. 168, 2820–2827.PubMedGoogle Scholar
  52. Wilson, C.B., Remington, J.S., Stagno, S., and Reynolds, D.W. (1980). Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 66, 767–774.PubMedGoogle Scholar
  53. Wu, C.Y., Demeure, C., Kiniwa, M., Gately, M., and Delespesse, G. (1993). IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J. Immunol. 151, 1938–1949.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • David A. Randolph
    • 1
    • 2
  • David B. Lewis
    • 2
    • 3
  1. 1.Department of Paediatrics and Division of ImmunologyStanford UniversityStanfordUSA
  2. 2.Stanford University School of MedicineStanfordUSA
  3. 3.Department of Paediatrics and the Program in ImmunologyStanford UniversityStanfordUSA

Personalised recommendations